OBRR Lab

The Food and Drug Administration is forecasting the procurement of a ZOE Fluorescent Cell/Fluorescent Cell Imager for use in its OBRR Lab, with the opportunity posted on May 25, 2026. The NAICS code 423450 indicates this is related to medical, dental, and hospital equipment and supplies merchant wholesaling, suggesting the acquisition is for specialized laboratory instrumentation rather than general supplies. The place of performance and exact location details are not specified, but the equipment is intended for internal use by the FDA's Center for Biologics Evaluation and Research. Program point of contact for inquiries is the Cber Acquisition Liaison at cberacquisitions@fda.hhs.gov, while the contracting officer role is listed as to be determined. There is no set-aside designation specified, meaning the contract is open to all eligible vendors without preference for small businesses or other categories. This forecast indicates a planned future solicitation, not an active announcement, and interested parties should monitor the OSDBU portal for the official RFP.